Dosage Drug Pricing Pharmaceutical Companies 
Drug Patent Watch
DECEMBER 18, 2024
Consider using a variety of claim types, including: Compound claims Method of treatment claims Formulation claims Dosage regimen claims Each type of claim offers different protections and can be valuable in different scenarios. Balancing Profit and Public Health Pharmaceutical companies face increasing scrutiny over drug pricing and access.
PharmExec
AUGUST 1, 2025
New labels will include study summaries, improved dosage warnings, and information on overdose reversal agents to enhance patient and healthcare professional awareness. The FDA mandates randomized clinical trials to assess long-term opioid use benefits and risks, ensuring timely and efficient completion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 23, 2025
This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.
Pharmaceutical Commerce
JUNE 9, 2025
As of now, supply for this coming season matches last year’s total dosage, with production expected to continue. Expanded manufacturing capacity for the upcoming season Now, the Sanofi-AstraZeneca partnership has resulted in tripled production capacity, along with twice the number of manufacturing facilities.
Viseven
JANUARY 13, 2023
Evaluation of drug efficiency on a dedicated market is a complex process that requires HEOR experts to measure multiple indicators to understand the actual market value of the product. So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? What is HEOR Data?
European Pharmaceutical Review
OCTOBER 19, 2022
Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment.
Pharmaceutical Technology
SEPTEMBER 26, 2022
Sandoz has a strong global brand and a unique heritage in areas ranging from generic antibiotics to biosimilars; it is also determined to differentiate itself as the off-patent company with the greatest focus on identifying and meeting patient needs.”. The company had revenues of $9.6bn both in 2020 and last year.
Expert insights. Personalized for you.
Let's personalize your content